| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193487 | Annals of Allergy, Asthma & Immunology | 2007 | 9 Pages |
Abstract
The pulmonary selectivity of ICSs can be improved by optimizing various PK/PD properties, which may lead to safer, more effective therapies for the treatment of asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Günther PhD,